Lioresal



Indications and Reactions:

Role Indications Reactions
Primary
Muscle Spasticity 96.5%
Cerebral Palsy 0.6%
Multiple Sclerosis 0.5%
Spinal Cord Injury 0.4%
Pain 0.3%
Hypertension 0.2%
Spasticity 0.2%
Dystonia 0.2%
Muscle Spasms 0.1%
Migraine 0.1%
Diabetes Mellitus 0.1%
Neuralgia 0.1%
Muscle Relaxant Therapy 0.1%
Spinal Cord Disorder 0.1%
Cerebrovascular Accident 0.1%
Brain Injury 0.1%
Head Injury 0.1%
Epilepsy 0.1%
Product Used For Unknown Indication 0.1%
Convulsion 0.1%
Hypertonia 18.1%
Drug Ineffective 10.5%
Withdrawal Syndrome 9.1%
Pain 7.4%
Death 7.1%
Muscle Spasticity 6.4%
Somnolence 4.6%
Overdose 4.3%
Therapeutic Response Decreased 4.2%
Infection 3.9%
Vomiting 3.4%
Pruritus 3.3%
Underdose 2.9%
Pyrexia 2.8%
Drug Withdrawal Syndrome 2.6%
Hypotonia 2.2%
Therapy Cessation 2.2%
Urinary Tract Infection 1.8%
Medical Device Complication 1.6%
Tremor 1.6%
Secondary
Product Used For Unknown Indication 20.8%
Drug Use For Unknown Indication 14.6%
Muscle Spasticity 13.5%
Pain 6.8%
Multiple Sclerosis 5.9%
Depression 5.1%
Hypertension 4.6%
Relapsing-remitting Multiple Sclerosis 3.8%
Epilepsy 3.4%
Muscle Spasms 3.1%
Drug Dependence 2.8%
Migraine 2.5%
Insomnia 2.1%
Cerebrovascular Accident 1.8%
Anxiety 1.7%
Sedation 1.7%
Anaemia 1.5%
Paraplegia 1.4%
Post Laminectomy Syndrome 1.4%
Trigeminal Neuralgia 1.4%
Thirst 9.9%
Somnolence 9.1%
Withdrawal Syndrome 8.3%
Pain 7.4%
Thrombocytopenia 7.4%
Vomiting 7.4%
Pancreatitis Acute 5.0%
Hypomania 4.1%
Irritability 4.1%
Muscle Spasticity 4.1%
Pyrexia 4.1%
Alanine Aminotransferase Increased 3.3%
Coma 3.3%
Epilepsy 3.3%
Infrequent Bowel Movements 3.3%
Seroma 3.3%
Sopor 3.3%
Toxic Encephalopathy 3.3%
Toxic Epidermal Necrolysis 3.3%
Angiopathy 2.5%
Concomitant
Multiple Sclerosis 20.5%
Product Used For Unknown Indication 12.8%
Pain 7.8%
Muscle Spasticity 7.4%
Drug Use For Unknown Indication 6.0%
Prophylaxis 5.7%
Relapsing-remitting Multiple Sclerosis 5.0%
Convulsion 4.4%
Hypertension 4.1%
Depression 3.5%
Epilepsy 3.3%
Amyotrophic Lateral Sclerosis 3.3%
Constipation 2.6%
Insomnia 2.5%
Hepatitis B 2.3%
Muscle Spasms 2.2%
Gastrooesophageal Reflux Disease 1.8%
Anxiety 1.7%
Analgesic Therapy 1.6%
Neuralgia 1.4%
Urinary Tract Infection 13.7%
Progressive Multifocal Leukoencephalopathy 9.7%
White Blood Cell Count Decreased 8.3%
Pneumonia 7.9%
Vomiting 6.1%
Urinary Retention 5.8%
Pyrexia 5.4%
Multiple Sclerosis Relapse 5.0%
Thrombocytopenia 5.0%
Blood Alkaline Phosphatase Increased 3.6%
Visual Impairment 3.6%
Somnolence 3.2%
Wheelchair User 3.2%
White Blood Cell Count Increased 3.2%
Muscular Weakness 2.9%
Pulmonary Embolism 2.9%
Wrong Technique In Drug Usage Process 2.9%
Lymphocytosis 2.5%
Muscle Spasticity 2.5%
Tachycardia 2.5%
Interacting
Huntington's Chorea 14.3%
Pain 14.3%
Product Used For Unknown Indication 14.3%
Acne 7.1%
Epilepsy 7.1%
Gastrooesophageal Reflux Disease 7.1%
Multiple Sclerosis 7.1%
Alcohol Detoxification 3.6%
Alcoholism 3.6%
Cervicobrachial Syndrome 3.6%
Depression 3.6%
Drug Use For Unknown Indication 3.6%
Muscle Spasms 3.6%
Musculoskeletal Pain 3.6%
Sleep Disorder 3.6%
Somnolence 21.4%
Drug Interaction 14.3%
Hypoxia 14.3%
Bradycardia 7.1%
Epilepsy 7.1%
Grand Mal Convulsion 7.1%
Hallucination, Visual 7.1%
Respiratory Depression 7.1%
Sopor 7.1%
Tremor 7.1%